Novo Nordisk A/S (NVO) vs Thermo Fisher Scientific Inc. (TMO)
A side-by-side comparison of Novo Nordisk A/S and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.
NVO
Novo Nordisk A/S
$47.08HealthcareDelayed quote: Jul 31, 2026, 3:59 PM EDT
TMO
Thermo Fisher Scientific Inc.
$574.30HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT
Total return — NVO vs TMO
growth of $100 · dividends reinvested · last 30yNVO +10806.6%TMO +1825.5%NVO compounded faster
Log scale — wide-divergence pair
NVO TMO
NVO vs TMO: by the numbers
- •TMO is the larger company ($213.42B vs $209.19B market cap).
- •NVO trades at the lower trailing earnings multiple (11.01 vs 31.71 P/E), one valuation lens rather than an overall verdict.
- •NVO converts more revenue to profit (37.14% vs 15.06% net margin).
- •NVO grew revenue faster over the past five years (20.73% vs 5.00% CAGR).
- •NVO pays the higher dividend yield (3.83% vs 0.31%).
Metrics side by side
Valuation
| Metric | NVO | TMO |
|---|---|---|
| P/E ratio | 11.01 | 31.71 |
| Forward P/E | N/A | 22.99 |
| P/S ratio | 4.09 | 4.76 |
| P/B ratio | 6.69 | 4.14 |
| PEG ratio | 8.16 | 4.54 |
| EV / EBITDA | 8.62 | 24.22 |
| FCF yield | 2.31% | 3.14% |
Profitability
| Metric | NVO | TMO |
|---|---|---|
| Gross margin | 81.83% | 40.37% |
| Operating margin | 45.21% | 17.69% |
| Net margin | 37.14% | 15.06% |
| ROE | 60.74% | 13.24% |
| ROIC | 29.53% | 7.58% |
Dividends
| Metric | NVO | TMO |
|---|---|---|
| Dividend yield | 3.83% | 0.31% |
| Payout ratio | 49.80% | 10.13% |
Growth (annualized)
| Metric | NVO | TMO |
|---|---|---|
| Revenue CAGR (5Y) | 20.73% | 5.00% |
| EPS CAGR (5Y) | 19.59% | 1.99% |
| FCF CAGR (5Y) | -5.86% | -1.83% |
| Total return CAGR (5Y) | 2.46% | 1.48% |
Frequently asked
- Which has the lower trailing P/E, NVO or TMO?
- NVO has the lower trailing P/E: NVO trades at 11.01 and TMO at 31.71. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, NVO or TMO?
- Over the past five years, NVO grew revenue faster — NVO at a 20.73% CAGR versus TMO at 5.00%.
- Does NVO or TMO pay a bigger dividend?
- NVO yields 3.83% and TMO yields 0.31% based on trailing dividends and the latest price.
- Is NVO or TMO more profitable?
- NVO runs the higher net margin — NVO at 37.14% versus TMO at 15.06%.
- How have NVO and TMO total returns compared?
- Over the past 10 years, NVO delivered 7.59% and TMO delivered 14.01% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Novo Nordisk A/S P/E ratioThermo Fisher Scientific P/E ratioNovo Nordisk A/S dividend yieldThermo Fisher Scientific dividend yieldNovo Nordisk A/S ROEThermo Fisher Scientific ROENovo Nordisk A/S operating marginThermo Fisher Scientific operating marginNovo Nordisk A/S revenue growthThermo Fisher Scientific revenue growthNovo Nordisk A/S free cash flowThermo Fisher Scientific free cash flow
Novo Nordisk A/S & Thermo Fisher Scientific appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.